SEC 13F Intelligence

Ghost Tree Capital, LLC / JANX

Ghost Tree Capital, LLC’s Janux Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Janux Therapeutics Inc (JANX)? Yes190.0K shares worth $9M (+2.61% of its 13F portfolio) as of Q3 2024, up from 50.0K shares the prior filed quarter.

Position Value
$9M
Q3 2024
Shares
190.0K
% of Portfolio
+2.61%
Quarters Held
2
currently held

Position History JANX

Reported value by quarter
Q2 ’24: $2MQ2 ’24Q3 ’24: $9MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024190.0K$9M+2.61%
Q2 202450.0K$2M+0.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of JANX.